de Luna Aguilar, A.M.; Fuentes, J.D.B.; Ortega Anselmi, J.; Olalla Inoa, J.; Flores Navarro, P.; Lopez de Sá, A.; Fuentes Antras, J.; Rodríguez Rey, C.; Ortega Candil, A.; Moreno Antón, F.;
et al. Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study. Cancers 2023, 15, 4452.
https://doi.org/10.3390/cancers15184452
AMA Style
de Luna Aguilar AM, Fuentes JDB, Ortega Anselmi J, Olalla Inoa J, Flores Navarro P, Lopez de Sá A, Fuentes Antras J, Rodríguez Rey C, Ortega Candil A, Moreno Antón F,
et al. Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study. Cancers. 2023; 15(18):4452.
https://doi.org/10.3390/cancers15184452
Chicago/Turabian Style
de Luna Aguilar, Alicia Milagros, Javier David Benitez Fuentes, Justo Ortega Anselmi, Jennifer Olalla Inoa, Paloma Flores Navarro, Alfonso Lopez de Sá, Jesus Fuentes Antras, Cristina Rodríguez Rey, Aída Ortega Candil, Fernando Moreno Antón,
and et al. 2023. "Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study" Cancers 15, no. 18: 4452.
https://doi.org/10.3390/cancers15184452
APA Style
de Luna Aguilar, A. M., Fuentes, J. D. B., Ortega Anselmi, J., Olalla Inoa, J., Flores Navarro, P., Lopez de Sá, A., Fuentes Antras, J., Rodríguez Rey, C., Ortega Candil, A., Moreno Antón, F., & García Sáenz, J. Á.
(2023). Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study. Cancers, 15(18), 4452.
https://doi.org/10.3390/cancers15184452